TYRA-200 is an orally active FGFR1/2/3 inhibitor that induces dose-dependent tumor regression in wild-type and mutant FGFR2 models, making it a candidate for advanced or metastatic intrahepatic cholangiocarcinoma.
Molecular Weight:
449.48
Purity:
99.56%
CAS Number:
[2823289-77-4]
Formula:
C23H24FN7O2
Target:
FGFR
T210495
* VAT and and shipping costs not included. Errors and price changes excepted